Long-circulating and target-specific nanoparticles: theory to practice.

The rapid recognition of intravenously injected colloidal carriers, such as liposomes and polymeric nanospheres from the blood by Kupffer cells, has initiated a surge of development for "Kupffer cell-evading" or long-circulating particles. Such carriers have applications in vascular drug delivery and release, site-specific targeting (passive as well as active targeting), as well as transfusion medicine. In this article we have critically reviewed and assessed the rational approaches in the design as well as the biological performance of such constructs. For engineering and design of long-circulating carriers, we have taken a lead from nature. Here, we have explored the surface mechanisms, which affords red blood cells long-circulatory lives and the ability of specific microorganisms to evade macrophage recognition. Our analysis is then centered where such strategies have been translated and fabricated to design a wide range of particulate carriers (e.g., nanospheres, liposomes, micelles, oil-in-water emulsions) with prolonged circulation and/or target specificity. With regard to the targeting issues, attention is particularly focused on the importance of physiological barriers and disease states.

[1]  M. Yokoyama Block copolymers as drug carriers. , 1992, Critical reviews in therapeutic drug carrier systems.

[2]  John W. Park,et al.  Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. , 1997, Biochemistry.

[3]  P. Low,et al.  Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. , 1994, The Journal of biological chemistry.

[4]  B. Goins,et al.  Blood-pool imaging using technetium-99m-labeled liposomes. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  D. Devine,et al.  Liposome-complement interactions in rat serum: implications for liposome survival studies. , 1994, Biochimica et biophysica acta.

[6]  D. Bazile,et al.  Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. , 1995, Journal of pharmaceutical sciences.

[7]  R. Hunter,et al.  CRL-1072 enhances antimycobacterial activity of human macrophages through interleukin-8. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[8]  V. Torchilin,et al.  CT visualization of blood pool in rats by using long-circulating, iodine-containing micelles. , 1999, Academic radiology.

[9]  J. Kreuter,et al.  Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants , 1990 .

[10]  L. P. Yasenchak,et al.  Tissue response to implanted polymers: the significance of sample shape. , 1976, Journal of biomedical materials research.

[11]  J. V. Von Roenn,et al.  Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  V. Torchilin,et al.  Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardium , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  Leaf Huang,et al.  Folate-targeted, Anionic Liposome-entrapped Polylysine-condensed DNA for Tumor Cell-specific Gene Transfer (*) , 1996, The Journal of Biological Chemistry.

[14]  Olivier Meyer,et al.  Copolymers of N‐isopropylacrylamide can trigger pH sensitivity to stable liposomes , 1998, FEBS letters.

[15]  S. Armes,et al.  Synthesis of Zwitterionic Shell Cross-Linked Micelles , 1999 .

[16]  W. Oyen,et al.  Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. , 2000, The Journal of pharmacology and experimental therapeutics.

[17]  J. Szebeni,et al.  The interaction of liposomes with the complement system. , 1998, Critical reviews in therapeutic drug carrier systems.

[18]  M. Naito,et al.  Macrophage heterogeneity in development and differentiation. , 1993, Archives of histology and cytology.

[19]  S. Seltzer The role of liposomes in diagnostic imaging. , 1989, Radiology.

[20]  G Gregoriadis,et al.  Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. , 1991, Biochimica et biophysica acta.

[21]  David J. Yang,et al.  Polyamino acid microspheres: Preparation, characterization and distribution after intravenous injection in rats , 1993 .

[22]  R. Melton,et al.  Covalent linkage of carboxypeptidase G2 to soluble dextrans--I. Properties of conjugates and effects on plasma persistence in mice. , 1987, Biochemical pharmacology.

[23]  G. Gregoriadis,et al.  Is half‐life of circulating liposomes determined by changes in their permeability? , 1982, FEBS letters.

[24]  M. Kazatchkine,et al.  Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b. , 1979, Journal of immunology.

[25]  D. Absolom Opsonins and dysopsonins: an overview. , 1986, Methods in enzymology.

[26]  T. Callisen,et al.  Increase in phospholipase A2 activity towards lipopolymer-containing liposomes. , 1998, Biochimica et biophysica acta.

[27]  W. Oyen,et al.  Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  S. Moghimi,et al.  Altered tissue-specific opsonic activities and opsono-recognition of liposomes in tumour-bearing rats. , 1996, Biochimica et biophysica acta.

[29]  D. Cabral,et al.  Mucoid Pseudomonas aeruginosa Resists Nonopsonic Phagocytosis by Human Neutrophils and Macrophages , 1987, Pediatric Research.

[30]  Moghimi,et al.  Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography. , 1999, Advanced drug delivery reviews.

[31]  Y. Nio,et al.  A quinolinone derivative, vesnarinone (OPC-8212), significantly inhibits the in vitro and in vivo growth of human pancreatic cancer cell lines , 1997, Anti-cancer drugs.

[32]  G. Gregoriadis,et al.  Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. , 1985, Biochimica et biophysica acta.

[33]  V. Torchilin,et al.  Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. , 1991, Biochimica et biophysica acta.

[34]  N. Van Rooijen,et al.  Transient suppression of macrophage functions by liposome-encapsulated drugs. , 1997, Trends in biotechnology.

[35]  S. Moghimi Mechanisms of splenic clearance of blood cells and particles : towards development of new splenotropic agents , 1995 .

[36]  H M Patel,et al.  Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes. , 1989, Biochimica et biophysica acta.

[37]  W. Phillips Use of Radiolabeled Liposomes for PEG-Liposome-Based Drug Targeting and Diagnostic Imaging Applications , 1998 .

[38]  B. Paton,et al.  A study of labeled pluronic F-68 after intravenous injection into the dog. , 1978, The Journal of surgical research.

[39]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[40]  T. Allen,et al.  Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine. , 1992, Cancer research.

[41]  J. Mulliken,et al.  E-selectin is present in proliferating endothelial cells in human hemangiomas. , 1996, The American journal of pathology.

[42]  Stephen E. Harding,et al.  Polylactide−Poly(ethylene glycol) Copolymers as Drug Delivery Systems. 1. Characterization of Water Dispersible Micelle-Forming Systems , 1996 .

[43]  L. Schook,et al.  Mechanisms generating functionally heterogeneous macrophages: chaos revisited , 1993, Journal of leukocyte biology.

[44]  D. Shotton,et al.  Purification and properties of sialoadhesin, a sialic acid‐binding receptor of murine tissue macrophages. , 1991, The EMBO journal.

[45]  H. Kikuchi,et al.  Phosphatidyl polyglycerols prolong liposome circulation in vivo , 1994 .

[46]  E. Moase,et al.  Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. , 1995, Biochimica et biophysica acta.

[47]  Suming Li,et al.  Enzymatic degradation of stereocopolymers derived from L-, DL- and meso-lactides , 2000 .

[48]  R Weissleder,et al.  MR lymphography: study of a high-efficiency lymphotrophic agent. , 1994, Radiology.

[49]  L. Huang,et al.  Effect of chemically modified GM1 and neoglycolipid analogs of GM1 on liposome circulation time: evidence supporting the dysopsonin hypothesis. , 1993, Biochimica et biophysica acta.

[50]  Devine,et al.  The complement system in liposome clearance: Can complement deposition be inhibited? , 1998, Advanced drug delivery reviews.

[51]  A. M. Lefer,et al.  Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury. , 1995, Cardiovascular research.

[52]  W. Oyen,et al.  Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[53]  M. Bally,et al.  The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: implications for drug delivery. , 1995, Biochimica et biophysica acta.

[54]  R K Jain,et al.  Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. , 1990, Journal of the National Cancer Institute.

[55]  K. Yamamoto,et al.  Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver , 1994, Hepatology.

[56]  Kostas Kostarelos,et al.  LIPOSOMES AS CARRIERS OF RADIONUCLIDES: FROM IMAGING TO THERAPY , 1999 .

[57]  Erkki Ruoslahti,et al.  αv Integrins as receptors for tumor targeting by circulating ligands , 1997, Nature Biotechnology.

[58]  G. Matyas,et al.  Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of "stealth" lipids. , 1991, Biochemical and biophysical research communications.

[59]  D. Fearon,et al.  Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[60]  D. Crommelin,et al.  Adhesion molecules: a new target for immunoliposome‐mediated drug delivery , 1995, FEBS letters.

[61]  W. Oyen,et al.  Detection of subacute infectious foci with indium-111-labeled autologous leukocytes and indium-111-labeled human nonspecific immunoglobulin G: a prospective comparative study. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[62]  T. Allen,et al.  A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. , 1995, Biochimica et biophysica acta.

[63]  M. Bally,et al.  Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. , 1998, Biochimica et biophysica acta.

[64]  S. Zalipsky Functionalized Poly(ethylene glycol) for Preparation of Biologically Relevant Conjugates , 1995 .

[65]  L. Weiss,et al.  Anatomical hazards to the passage of erythrocytes through the spleen. , 1970, Seminars in hematology.

[66]  J. Swanson,et al.  Delivery of Macromolecules into Cytosol Using Liposomes Containing Hemolysin from Listeria monocytogenes(*) , 1996, The Journal of Biological Chemistry.

[67]  Gert Storm,et al.  Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .

[68]  D. Devine,et al.  The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. , 1991, Journal of immunology.

[69]  Poloxamer-188 revisited: a potentially valuable immune modulator. , 1996, Journal of the National Cancer Institute.

[70]  R. Steinman,et al.  Liver macrophages in murine listeriosis. Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates , 1985, The Journal of experimental medicine.

[71]  F. Davis,et al.  Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. , 1977, The Journal of biological chemistry.

[72]  Thomas N. Sato,et al.  Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation , 1995, Nature.

[73]  Amarpreet S. Sawhney,et al.  Poly(ethylene glycol) , 1999 .

[74]  R. Langer,et al.  A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. , 1997, Journal of pharmaceutical sciences.

[75]  Y. Quinn,et al.  New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine. , 1999, Bioconjugate chemistry.

[76]  I. Kovesdi,et al.  Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation , 1997, Cancer Immunology, Immunotherapy.

[77]  Luke S. S. Guo,et al.  Sialyl Lewis x Liposomes as a Multivalent Ligand and Inhibitor of E-Selectin Mediated Cellular Adhesion , 1996 .

[78]  P. Couvreur,et al.  Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[79]  G. Cornelis,et al.  Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules , 1993, Infection and immunity.

[80]  L. Hamilton,et al.  Observations of cattle, goats and pigs after administration of synthetic interferon inducers and subsequent exposure to foot and mouth disease virus. , 1973, Canadian journal of comparative medicine : Revue canadienne de medecine comparee.

[81]  J. Robert,et al.  Failure of liposomal encapsulation of doxorubicin to circumvent multidrug resistance in an in vitro model of rat glioblastoma cells. , 1995, European journal of cancer.

[82]  C. Alving,et al.  Complement-Dependent Phagocytosis of Liposomes: Suppression by “Stealth” Lipids , 1992 .

[83]  T. Tadros,et al.  Physical Conjugation of (Tri-) Block Copolymers to Liposomes toward the Construction of Sterically Stabilized Vesicle Systems , 1999 .

[84]  A. Gabizon,et al.  Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. , 1991, Biochimica et biophysica acta.

[85]  G. Gregoriadis,et al.  Polysialylated asparaginase: preparation, activity and pharmacokinetics. , 1997, Biochimica et biophysica acta.

[86]  C. Alving Macrophages as targets for delivery of liposome-encapsulated antimicrobial agents , 1988 .

[87]  M. Bally,et al.  Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol). , 2001, Biochimica et biophysica acta.

[88]  D. Mason,et al.  Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. , 1986, Immunology.

[89]  M. Smith,et al.  Human spleen contains phenotypic subsets of macrophages and dendritic cells that occupy discrete microanatomic locations. , 1987, The American journal of pathology.

[90]  P. Crocker,et al.  Sialic acid binding receptors (siglecs) expressed by macrophages , 1999, Journal of leukocyte biology.

[91]  G. Storm,et al.  Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. , 1993, Biochimica et biophysica acta.

[92]  M. Telen,et al.  Rh-related antigen CD47 is the signal-transducer integrin-associated protein. , 1994, The Journal of biological chemistry.

[93]  L. Huang,et al.  Effect of matrix lipid chain length on liposomes containing cholesterol and ganglioside GM1: implications in drug delivery. , 1996, Journal of pharmaceutical sciences.

[94]  W. Oyen,et al.  Technetium-99m-labeled liposomes to image experimental colitis in rabbits: comparison with technetium-99m-HMPAO-granulocytes and technetium-99m-HYNIC-IgG. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[95]  M. Yatvin,et al.  pH-sensitive liposomes: possible clinical implications. , 1980, Science.

[96]  S. Ram,et al.  A Novel Sialic Acid Binding Site on Factor H Mediates Serum Resistance of Sialylated Neisseria gonorrhoeae , 1998, The Journal of experimental medicine.

[97]  T. Allen Long-circulating (sterically stabilized) liposomes for targeted drug delivery. , 1994, Trends in pharmacological sciences.

[98]  Moghimi,et al.  Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - The concept of tissue specificity. , 1998, Advanced drug delivery reviews.

[99]  D. Birmingham,et al.  Primate erythrocyte-immune complex-clearing mechanism. , 1983, The Journal of clinical investigation.

[100]  M. Schmidt,et al.  The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. , 1981, European journal of biochemistry.

[101]  V. Perry,et al.  Antigen markers of macrophage differentiation in murine tissues. , 1992, Current topics in microbiology and immunology.

[102]  M. Dewhirst,et al.  Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[103]  A. Surolia,et al.  Monosialoganglioside liposome-entrapped enzyme uptake by hepatic cells. , 1977, Biochimica et biophysica acta.

[104]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[105]  D. Williams,et al.  Enzyme-accelerated hydrolysis of polyglycolic acid. , 1977, Journal of bioengineering.

[106]  S. Moghimi,et al.  Differential properties of organ-specific serum opsonins for liver and spleen macrophages. , 1989, Biochimica et biophysica acta.

[107]  P. D'Arcy Hart,et al.  Effects of non‐ionic surfactants that modify experimental tuberculosis on lipase activity of macrophages , 1971, British journal of pharmacology.

[108]  S M Moghimi,et al.  Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. , 2000, Trends in biotechnology.

[109]  P. Stauffer,et al.  Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. , 1994, Cancer research.

[110]  Erkki Ruoslahti,et al.  Anti-cancer activity of targeted pro-apoptotic peptides , 1999, Nature Medicine.

[111]  M. Sawada,et al.  Effects of glycophorin and ganglioside GM3 on the blood circulation and tissue distribution of liposomes in rats , 1993 .

[112]  T. Wileman Properties of asparaginase-dextran conjugates , 1991 .

[113]  J. Feijen,et al.  The effect of phagocytosis of poly(L-lactic acid) fragments on cellular morphology and viability. , 1993, Journal of biomedical materials research.

[114]  K. Higashi,et al.  Effects of sialic acid derivative on long circulation time and tumor concentration of liposomes , 1995 .

[115]  R. J. Lee,et al.  Targeted drug delivery via the folate receptor. , 2000, Advanced drug delivery reviews.

[116]  S. Davis,et al.  Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. , 1991, Biochemical and biophysical research communications.

[117]  G. Frija,et al.  MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement. , 1994, AJR. American journal of roentgenology.

[118]  X. Wu,et al.  Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: Part II. Biodegradation and drug delivery application. , 1997, Journal of biomaterials science. Polymer edition.

[119]  S. Benita Kinetic model identification of drug release from microcapsules using the nonlinear regression search procedure. , 1984, Applied biochemistry and biotechnology.

[120]  J. Feijen,et al.  Cellular Uptake of PEO Surface-Modified Nanoparticles: Evaluation of Nanoparticles Made of PLA: PEO Diblock and Triblock Copolymers , 2000, Journal of drug targeting.

[121]  L. Weiss,et al.  Mechanisms of splenic control of murine malaria: reticular cell activation and the development of a blood-spleen barrier. , 1986, The American journal of anatomy.

[122]  B. Lundberg A Submicron Lipid Emulsion Coated with Amphipathic Polyethylene Glycol for Parenteral Administration of Paclitaxel (Taxol) , 1997, The Journal of pharmacy and pharmacology.

[123]  N. Hogg,et al.  Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. , 1988, The Journal of clinical investigation.

[124]  Y. Takei,et al.  Liposome‐encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro , 1996, Journal of leukocyte biology.

[125]  P Couvreur,et al.  Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. , 1997, Life sciences.

[126]  D. Cheresh Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[127]  T M Allen,et al.  Large unilamellar liposomes with low uptake into the reticuloendothelial system , 1987, FEBS letters.

[128]  Samuel Zalipsky,et al.  Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface‐grafted poly(ethylene glycol) , 1996, FEBS letters.

[129]  M. Poznansky,et al.  Biological approaches to the controlled delivery of drugs: a critical review. , 1984, Pharmacological reviews.

[130]  H. Bayley,et al.  Tumor protease-activated, pore-forming toxins from a combinatorial library , 1996, Nature Biotechnology.

[131]  C. Alving,et al.  Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity. , 1991, Critical reviews in immunology.

[132]  K. D. Lee,et al.  Bacterial pore-forming hemolysins and their use in the cytosolic delivery of macromolecules. , 2000, Advanced drug delivery reviews.

[133]  M. Dierich,et al.  Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55) , 1996, The Journal of experimental medicine.

[134]  M C Davies,et al.  Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer. , 1997, Biomaterials.

[135]  Tomoo Suzuki,et al.  Hydrolysis of polyesters by lipases , 1977, Nature.

[136]  S. Benita,et al.  Fundamentals of release mechanism interpretation in multiparticulate systems: determination of substrate release from single microcapsules and relation between individual and ensemble release kinetics , 1986 .

[137]  H. Friess,et al.  Over‐expression of ICAM‐1, VCAM‐1 and ELAM‐1 might influence tumor progression in colorectal cancer , 1998, International journal of cancer.

[138]  W. R. Bruce,et al.  Studies on the persistence of methotrexate, cytosine arabinoside, and leucovorin in serum of mice. , 1969, Journal of the National Cancer Institute.

[139]  M C Garnett,et al.  Preparation of surface-modified albumin nanospheres. , 1997, Biomaterials.

[140]  I. Macdonald,et al.  Microcirculation in mouse spleen (nonsinusal) studied by means of corrosion casts , 1985, Journal of morphology.

[141]  S. Meri,et al.  Localization of the heparin-binding site on complement factor H. , 1991, The Journal of biological chemistry.

[142]  R. Means,et al.  A role for carbohydrates in immune evasion in AIDS , 1998, Nature Medicine.

[143]  D. Breslow Biologically Active Synthetic Polymers , 1976 .

[144]  A. Gabizon,et al.  The role of surface charge and hydrophilic groups on liposome clearance in vivo. , 1992, Biochimica et biophysica acta.

[145]  W. Oyen,et al.  Sterically stabilized liposomes labeled with indium-111 to image focal infection. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[146]  T. Allen,et al.  Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes. , 1996, Journal of pharmaceutical sciences.

[147]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[148]  C. G. Pitt,et al.  Poly (glycolic acid-co-dl-lactic acid): diffusion or degradation controlled drug delivery? , 1992 .

[149]  S. Stewart,et al.  Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[150]  T. D. Madden,et al.  LIPOSOMAL CYCLOSPORINE: CHARACTERIZATION OF DRUG INCORPORATION AND INTERBILAYER EXCHANGE , 1995, Transplantation.

[151]  C. Bucana,et al.  Enhancement of murine tumor cell sensitivity to adriamycin by presentation of the drug in phosphatidylcholine-phosphatidylserine liposomes. , 1990, Cancer research.

[152]  G. Koning,et al.  On the mechanism of hepatic transendothelial passage of large liposomes , 1999, FEBS letters.

[153]  S. Davis,et al.  Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan‐stimulated rats , 1993, Journal of leukocyte biology.

[154]  W. Oyen,et al.  Technetium-99m labelled liposomes to image experimental arthritis , 1997, Annals of the rheumatic diseases.

[155]  R. Hunter,et al.  The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers. , 1984, Journal of immunology.

[156]  S. M. Moghimi Prolonging the circulation time and modifying the body distribution of intravenously injected polystyrene nanospheres by prior intravenous administration of poloxamine-908. A 'hepatic-blockade' event or manipulation of nanosphere surface in vivo? , 1997, Biochimica et biophysica acta.

[157]  M. Pangburn,et al.  Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[158]  P. Arese,et al.  Enhanced IgG‐ and complement‐independent phagocytosis of sulfatide‐enriched human erythrocytes by human monocytes , 1992, FEBS letters.

[159]  Alving Cr,et al.  Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity. , 1991 .

[160]  S. Moghimi,et al.  Exploiting bone marrow microvascular structure for drug delivery and future therapies , 1995 .

[161]  Robert B Sim,et al.  Pattern of degradation of human complement fragment, C3b , 1981, FEBS letters.

[162]  C. Nast,et al.  Oxygen-dependent up-regulation of mucoid exopolysaccharide (alginate) production in Pseudomonas aeruginosa , 1990, Infection and immunity.

[163]  K. Maruyama,et al.  Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). , 1992, Biochimica et biophysica acta.

[164]  Lawrence Mayer,et al.  Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel , 1997, Anti-cancer drugs.

[165]  S. Jiang,et al.  Roles of a macrophage receptor with collagenous structure (MARCO) in host defense and heterogeneity of splenic marginal zone macrophages. , 1999, Archives of histology and cytology.

[166]  V. Torchilin,et al.  Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo , 1991, FEBS letters.

[167]  T. Okano,et al.  Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. , 1991, Cancer research.

[168]  B. Harvey,et al.  Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ , 1997, Journal of virology.

[169]  P. Cullis,et al.  β2-Glycoprotein I Is a Major Protein Associated with Very Rapidly Cleared Liposomes in Vivo, Suggesting a Significant Role in the Immune Clearance of "Non-self" Particles (*) , 1995, The Journal of Biological Chemistry.

[170]  V. Kolb-Bachofen,et al.  Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. , 1993, Biochimica et biophysica acta.

[171]  D. Papahadjopoulos,et al.  Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.

[172]  S. Kumar,et al.  Heterogeneity in endothelial cells from large vessels and microvessels. , 1987, Differentiation; research in biological diversity.

[173]  Dunn Se Biodegradable nanosphere systems for drug targeting : with emphasis on systems for bone marrow targeting. , 1995 .

[174]  S. Davis,et al.  An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. , 1993, Biochimica et biophysica acta.

[175]  T. Kowalewski,et al.  Water-Soluble Knedel-like Structures: The Preparation of Shell-Cross-Linked Small Particles , 1996 .

[176]  S. Perren,et al.  Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). , 1993, Journal of biomedical materials research.

[177]  Yoshiharu Doi,et al.  Thermal degradation of microbial copolyesters: poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and poly(3-hydroxybutyrate-co-4-hydroxybutyrate) , 1990 .

[178]  M. Jones,et al.  Polymeric micelles - a new generation of colloidal drug carriers. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[179]  T. Sodeman,et al.  Pitting Function of the Spleen in Malaria: Ultrastructural Observations , 1972, Science.

[180]  S. Lee,et al.  Macrophage plasma membrane and secretory properties in murine malaria. Effects of Plasmodium yoelii blood-stage infection on macrophages in liver, spleen, and blood , 1986, The Journal of experimental medicine.

[181]  V. Fischetti,et al.  Variation in the expression of cell wall proteins of Staphylococcus aureus grown on solid and liquid media , 1988, Infection and immunity.

[182]  V. Torchilin,et al.  Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo. , 1994, Biochimica et biophysica acta.

[183]  W. Oyen,et al.  Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. , 1999, Biochimica et biophysica acta.

[184]  N. Mullah,et al.  Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains. , 1997, Bioconjugate chemistry.

[185]  M P Bevilacqua,et al.  Endothelial-leukocyte adhesion molecules. , 1993, Annual review of immunology.

[186]  C. G. Gebelein,et al.  Biomedical and Dental Applications of Polymers , 1981 .

[187]  J. Kohn,et al.  Trends in the Development of Bioresorbable Polymers for Medical Applications , 1992, Journal of biomaterials applications.

[188]  P. Flandroy,et al.  Control of the biodegradation rate of poly (dl-lactide) microparticles intended as chemoembolization materials , 1996 .

[189]  Robert M. Ziff,et al.  Kinetics of polymer degradation , 1986 .

[190]  B. Tromberg,et al.  Fluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissue. , 1996, Cancer research.

[191]  T. Snook A comparative study of the vascular arrangements in mammalian spleens. , 1950, The American journal of anatomy.

[192]  C. Lagenaur,et al.  Role of CD47 as a marker of self on red blood cells. , 2000, Science.

[193]  M. Schmidt,et al.  The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. , 1981, European journal of biochemistry.

[194]  E. W. Meijer,et al.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[195]  J. Healey,et al.  Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[196]  N. Phillips,et al.  Immunoliposome targeting to murine CD4+ leucocytes is dependent on immune status. , 1994, Journal of immunology.

[197]  N. Narula,et al.  Anti-KCA-3, a monoclonal antibody reactive with a rat complement C3 receptor, distinguishes Kupffer cells from other macrophages. , 1993, Journal of immunology.

[198]  S. Benita,et al.  Variation of Population Release Kinetics in Polydisperse Multiparticulate Systems (Microcapsules, Microspheres, Droplets, Cells) with Heterogeneity of One, Two or Three Parameters in the Population of Individuals , 1988, The Journal of pharmacy and pharmacology.

[199]  J. Murray,et al.  Activation of Complement by Fluosol Attributable to the Pluronic Detergent Micelle Structure , 1993, Journal of cardiovascular pharmacology.

[200]  S. Moghimi,et al.  Variation of complement activation in human serum by Poloxamer 188 (Pluronic-F68) , 2001 .

[201]  Ulrich Keilholz,et al.  Immunohistochemical analysis of integrin αvβ3 expression on tumor‐associated vessels of human carcinomas , 1997 .

[202]  S. Davis,et al.  The polyoxyethylene/polyoxypropylene block co‐polymer Poloxamer‐407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow , 1992, FEBS letters.

[203]  F M Muggia,et al.  Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. , 1998, Journal of the National Cancer Institute.

[204]  R. Hunter,et al.  Induction of macrophage Ia expression in vivo by a synthetic block copolymer, L81. , 1990, Journal of immunology.

[205]  D. Williams,et al.  Molecular biointeractions of biomedical polymers with extracellular exudate and inflammatory cells and their effects on the biocompatibility, in vivo. , 1994, Biomaterials.

[206]  S. Goerdt,et al.  A monoclonal antibody reacting with endothelial cells of budding vessels in tumors and inflammatory tissues, and non‐reactive with normal adult tissues , 1986, International journal of cancer.

[207]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[208]  I. Ahmad,et al.  Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. , 1993, Cancer research.

[209]  L. Huang,et al.  Some negatively charged phospholipid derivatives prolong the liposome circulation in vivo. , 1992, Biochimica et biophysica acta.

[210]  T. Allen The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system , 1994 .

[211]  K. Lowe,et al.  Evaluation of commercial and purified Pluronic F-68 in a human blood neutrophil bioassay. , 1999, Artificial cells, blood substitutes, and immobilization biotechnology.

[212]  S. Davis,et al.  Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. , 1994, Critical reviews in therapeutic drug carrier systems.

[213]  K. Caldwell,et al.  Surface Properties of Pluronic-Coated Polymeric Colloids , 1994 .

[214]  Z. Y. Wang,et al.  Disposition in rats of a polyoxypropylene-polyoxyethylene copolymer used in plasma fractionation. , 1975, Drug metabolism and disposition: the biological fate of chemicals.

[215]  G. Scherphof,et al.  Intrahepatic uptake and processing of intravenously injected small unilamellar phospholipid vesicles in rats. , 1984, Biochimica et biophysica acta.

[216]  J. Richmond,et al.  Enhancement, by Two Carboxylic Acid Interferon Inducers, of Resistance Stimulated in Mice by Foot-and-Mouth Disease Vaccine , 1973, Infection and immunity.

[217]  C. M. Gupta,et al.  Tuftsin-bearing liposomes in treatment of macrophage-based infections. , 2000, Advanced drug delivery reviews.

[218]  A. Gabizon,et al.  Liposome circulation time and tumor targeting: implications for cancer chemotherapy , 1995 .

[219]  E. Schacht,et al.  Preparation and in vitro characterization of HSA-mPEG nanoparticles. , 1999, International journal of pharmaceutics.

[220]  M. Gertsenstein,et al.  Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. , 1994, Genes & development.

[221]  R. Mandrell,et al.  Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants. , 1982, Journal of immunology.

[222]  G. Hofstede,et al.  Liposomal doxorubicin‐induced toxicity: Depletion and impairment of phagocytic activity of liver macrophages , 1995, International journal of cancer.

[223]  M. Woodle,et al.  Sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.

[224]  K. Caldwell,et al.  Chemical modification of surface active poly(ethylene oxide)-poly (propylene oxide) triblock copolymers. , 1996, Bioconjugate chemistry.

[225]  M A Tracy,et al.  Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. , 1999, Biomaterials.

[226]  S. Benita,et al.  Direct measurements on individual microcapsule dissolution as a tool for determination of release mechanism , 1986, The Journal of pharmacy and pharmacology.

[227]  A. Tulpule,et al.  Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[228]  M. Lifely,et al.  Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide , 1985, Infection and immunity.

[229]  M. Keltai,et al.  The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction. , 1997, Clinical hemorheology and microcirculation.

[230]  L. Huang,et al.  Large liposomes containing ganglioside GM1 accumulate effectively in spleen. , 1991, Biochimica et biophysica acta.

[231]  P. Volberding,et al.  Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma , 1996, Journal of clinical pharmacology.

[232]  S. Davis,et al.  The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338) , 1984, FEBS letters.

[233]  T. Gray,et al.  Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes , 1994, FEBS letters.

[234]  C. Mold,et al.  Effect of gangliosides on activation of the alternative pathway of human complement. , 1988, Journal of immunology.

[235]  Abrams Rm,et al.  Liposome disposition in vivo: effects of pre-dosing with lipsomes. , 1980 .

[236]  Humoral-mediated recognition of 'phagocyte-resistant' beads by lymph node macrophages of poloxamine-treated rats. , 1998, Clinical science.

[237]  Y. Barenholz,et al.  Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[238]  D. Crommelin,et al.  Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose. , 1997, Biochimica et biophysica acta.

[239]  P. Densen,et al.  Phagocyte strategy vs. microbial tactics. , 1980, Reviews of infectious diseases.

[240]  R. Horstmann,et al.  Location of the complement factor H binding site on streptococcal M6 protein , 1995, Infection and immunity.

[241]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[242]  G. Gregoriadis,et al.  Polysialic acids: potential in drug delivery , 1993, FEBS letters.

[243]  B. Bennett,et al.  The Adjuvant Activity of Nonionic Block Polymer Surfactants , 1986, Scandinavian journal of immunology.

[244]  T. K. van den Berg,et al.  Manipulation of Macrophage Activities Using Liposomes , 2000 .

[245]  H. Morselt,et al.  Secretion pattern of the rat liver macrophage population following activation with liposomal muramyl dipeptide in vivo and in vitro. , 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[246]  T. Allen,et al.  Insertion of poly(ethylene glycol) derivatized phospholipid into pre‐formed liposomes results in prolonged in vivo circulation time , 1996, FEBS letters.

[247]  M. Kazatchkine,et al.  Human liver Kupffer cells express CR1, CR3, and CR4 complement receptor antigens. An immunohistochemical study. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[248]  G. Kraal Cells in the marginal zone of the spleen. , 1992, International review of cytology.

[249]  B. Goins,et al.  Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[250]  T. Allen,et al.  Pharmacokinetics of stealth versus conventional liposomes: effect of dose. , 1991, Biochimica et biophysica acta.

[251]  Daniel Dexter,et al.  An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel , 1997, Cancer Chemotherapy and Pharmacology.

[252]  F. Emmrich,et al.  Apoptotic cell death in activated monocytes following incorporation of clodronate‐liposomes , 1996, Journal of leukocyte biology.

[253]  S. Bhatia,et al.  Enhancement of the in vivo circulation lifetime of L-alpha-distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization. , 1997, Biochimica et biophysica acta.

[254]  D. Friend,et al.  Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. , 1992, Cancer research.

[255]  M. Cybulsky,et al.  Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[256]  T. Chang,et al.  Comparison of polymerically stabilized PEG-grafted liposomes and physically adsorbed carboxymethylchitin and carboxymethyl/glycolchitin liposomes for biological applications. , 1998, Biomaterials.

[257]  P. A. Martic,et al.  Protein adsorption on pluronic copolymer-coated polystyrene particles , 1989 .

[258]  L. Huang,et al.  Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen. , 1992, Biochimica et biophysica acta.

[259]  K. Wirtz,et al.  Interaction of C-reactive protein with artificial phosphatidylcholine bilayers , 1979, Nature.

[260]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[261]  L. Andrac,et al.  ELAM selectin expression in breast carcinomas detected by automated and quantitative immunohistochemical assays. , 1998, International journal of oncology.

[262]  V. Torchilin,et al.  Stable polymeric micelles: lymphangiographic contrast media for gamma scintigraphy and magnetic resonance imaging. , 1996, Academic radiology.

[263]  P. Cullis,et al.  Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. , 1992, The Journal of biological chemistry.

[264]  P. Cullis,et al.  Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles. , 1994, Biochimica et biophysica acta.

[265]  T. Allen,et al.  Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. , 1989, Biochimica et biophysica acta.

[266]  Teruo Okano,et al.  Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-Adriamycin conjugates , 1994 .

[267]  J. Murray,et al.  Phagocytic activation of human neutrophils by the detergent component of fluosol. , 1992, The American journal of pathology.

[268]  J. Sunamoto,et al.  Surface Coating of Liposomes with Hydrophobized Polysaccharides , 1997 .

[269]  C. Passirani,et al.  Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). , 1998, Pharmaceutical research.

[270]  M. Woodle,et al.  New amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes. , 1994, Bioconjugate chemistry.

[271]  J. Rosenecker,et al.  Increased liposome extravasation in selected tissues: effect of substance P. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[272]  P. Couvreur,et al.  Stability of orosomucoid-coated polyisobutylcyanoacrylate nanoparticles in the presence of serum , 1996 .

[273]  L. Weiss,et al.  The role of the sinus wall in the passage of erythrocytes through the spleen. , 1973, Blood.

[274]  Patrick Couvreur,et al.  Synthesis of a Novel Poly(MePEG cyanoacrylate-co-alkyl cyanoacrylate) Amphiphilic Copolymer for Nanoparticle Technology‡ , 1997 .

[275]  Y. M. Lee,et al.  Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[276]  R. Melton,et al.  Covalent linkage of carboxypeptidase G2 to soluble dextrans--II. In vivo distribution and fate of conjugates. , 1987, Biochemical pharmacology.

[277]  P. Caliceti,et al.  New synthetic amphiphilic polymers for steric protection of liposomes in vivo. , 1995, Journal of pharmaceutical sciences.

[278]  M. Dierich,et al.  Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b , 1985, Infection and immunity.

[279]  K. K. Modowal,et al.  Mortality of patients with acute myocardial infarction. , 1973, Current medical research and opinion.

[280]  D. Absolom [13] Opsonins and dysopsonins: An overview , 1986 .

[281]  L. T. Chen Intrasplenic microcirculation in rats with acute hemolytic anemia. , 1980, Blood.

[282]  N. Copeland,et al.  A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[283]  H. Bengele,et al.  Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration. , 1994, Magnetic resonance imaging.

[284]  M. Woodle,et al.  Peptide attachment to extremities of liposomal surface grafted PEG chains: preparation of the long-circulating form of laminin pentapeptide, YIGSR. , 1995, Bioconjugate chemistry.

[285]  S. M. Moghimi Re-establishing the long circulatory behaviour of poloxamine-coated particles after repeated intravenous administration: applications in cancer drug delivery and imaging. , 1999, Biochimica et biophysica acta.

[286]  R. Cotran,et al.  Cytokines and endothelial cell biology. , 1990, Physiological reviews.

[287]  M C Davies,et al.  Poly(organo phosphazene) nanoparticles surface modified with poly(ethylene oxide). , 1996, Biotechnology and bioengineering.

[288]  J. Baker,et al.  Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[289]  S. Shreeve,et al.  Heterogeneity of vascular endothelial cells in normal and disease states. , 1998, Pharmacology & therapeutics.

[290]  A. Gabizon,et al.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[291]  S. Davis,et al.  Lymph node localisation of biodegradable nanospheres surface modified with poloxamer and poloxamine block co‐polymers , 1997, FEBS letters.

[292]  P. Lin,et al.  Effect of tumour necrosis factor, heat, and radiation on the viability and microfilament organization in cultured endothelial cells. , 1992, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[293]  D. Drenckhahn,et al.  Stress fibers in the splenic sinus endothelium in situ: molecular structure, relationship to the extracellular matrix, and contractility , 1986, The Journal of cell biology.

[294]  I. Ahmad,et al.  Immunoliposome-mediated targeting of anti-cancer drugs in vivo. , 1995, Biochemical Society transactions.

[295]  T. Allen,et al.  Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. , 1991, Biochimica et biophysica acta.

[296]  F. Veronese,et al.  Stabilization of substances in circulation. , 1998, Bioconjugate chemistry.

[297]  エマニユエル,アール・マーテイン,et al.  Polyoxypropylene / polyoxyethylene copolymers with improved biological activity , 1992 .

[298]  F. Braet,et al.  Structure and dynamics of the fenestrae‐associated cytoskeleton of rat liver sinusoidal endothelial cells , 1995, Hepatology.

[299]  A. Groom,et al.  The Microcirculatory Society Eugene M. Landis award lecture. Microcirculation of the spleen: new concepts, new challenges. , 1987, Microvascular research.

[300]  M. Woodle,et al.  Controlling liposome blood clearance by surface-grafted polymers. , 1998, Advanced drug delivery reviews.

[301]  D. Tzemach,et al.  Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[302]  M. Davies,et al.  Differences in the molecular weight profile of poloxamer 407 affect its ability to redirect intravenously administered colloids to the bone marrow , 1992 .

[303]  I. Bakker-Woudenberg,et al.  Toxicity of doxorubicin entrapped within long-circulating liposomes , 1997 .

[304]  F. Jamar,et al.  A comparison between 111In-anti-E-selectin mAb and 99Tcm-labelled human non-specific immunoglobulin in radionuclide imaging of rheumatoid arthritis. , 1997, The British journal of radiology.

[305]  K. Alitalo,et al.  Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? , 1998, The American journal of pathology.

[306]  S. Zalipsky Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. , 1995, Bioconjugate chemistry.

[307]  J. White,et al.  Pluronic F-68 reduces the endothelial adherence and improves the rheology of liganded sickle erythrocytes. , 1987, Blood.

[308]  T. Gray,et al.  A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats. , 1997, Clinical science.

[309]  Y. Yarden,et al.  Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies. , 1996, British Journal of Cancer.

[310]  N. Bjoerkman,et al.  ULTRASTRUCTURAL ALTERATIONS IN SINUSOIDAL ENDOTHELIUM OF LIVER AND BONE MARROW IN DOGS WITH EXPERIMENTAL HEPATITIS CONTAGIOSA CANIS. , 1964, Acta pathologica et microbiologica Scandinavica.

[311]  H. Kehlen,et al.  Continuous kinetics of first order degradation reactions in polydisperse mixtures , 1988 .

[312]  T. Okano,et al.  Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. , 1990, Cancer research.

[313]  W. Bochenek,et al.  Absorption and excretion of the hydrophobic surfactant, 14C-poloxalene 2930, in the rat. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[314]  H M Patel,et al.  Serum opsonins and liposomes: their interaction and opsonophagocytosis. , 1992, Critical reviews in therapeutic drug carrier systems.

[315]  R. Jain,et al.  Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.

[316]  M. Bally,et al.  Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol). , 1997, The Journal of pharmacology and experimental therapeutics.

[317]  C. Hulstaert,et al.  Heterogeneity of rat liver and spleen macrophages in gadolinium chloride–induced elimination and repopulation , 1992, Journal of leukocyte biology.

[318]  W. Lin The preparation and characterization of surface modified albumin nanoparticles for site specific drug delivery. , 1996 .

[319]  K. Lowe,et al.  Purification of Pluronic F‐68 for perfluorochemical emulsification * , 1989, The Journal of pharmacy and pharmacology.

[320]  S. Moghimi,et al.  Advanced colloid-based systems for efficient delivery of drugs and diagnostic agents to the lymphatic tissues. , 1996, Progress in biophysics and molecular biology.

[321]  F. Martin,et al.  Liposome leakage and blood circulation: Comparison of adsorbed block copolymers with covalent attachment of PEG , 1992 .

[322]  S. Gordon,et al.  Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody , 1989, The Journal of experimental medicine.

[323]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[324]  S. Kennel,et al.  Lipid composition is important for highly efficient target binding and retention of immunoliposomes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[325]  S. Rössner,et al.  The influence of emulsifying agents and of lipid soluble drugs on the fractional removal rate of lipid emulsions from the blood stream of the rabbit. , 2009, Acta pharmacologica et toxicologica.

[326]  B. Baguley,et al.  Plasma half-life of cytosine arabinoside (NSC-63878) in patients treated for acute myeloblastic leukemia. , 1971, Cancer chemotherapy reports.

[327]  John W. Park,et al.  Development of anti-p185HER2 immunoliposomes for cancer therapy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[328]  A. Griffioen,et al.  Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. , 2000, Pharmacological reviews.

[329]  Suming Li,et al.  Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. , 1995, Biomaterials.

[330]  A. U. Daniels,et al.  Mechanical properties of biodegradable polymers and composites proposed for internal fixation of bone. , 1990, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[331]  G. Nicolson,et al.  Differential expression of cell surface glycoproteins on various organ‐derived microvascular endothelia and endothelial cell cultures , 1988, Journal of cellular physiology.

[332]  N. Oku,et al.  Liposomal modification with uronate, which endows liposomes with long circulation in vivo, reduces the uptake of liposomes by J774 cells in vitro. , 1992, Life sciences.

[333]  W. Oyen,et al.  99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[334]  Y. Lee,et al.  Methoxy poly(ethylene glycol)/?-caprolactone amphiphilic block copolymeric micelle containing indome , 1998 .

[335]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[336]  N. Oku,et al.  Long-circulating liposomes. , 1994, Critical reviews in therapeutic drug carrier systems.

[337]  N. Oku,et al.  Tumor accumulation of novel RES-avoiding liposomes. , 1992, Biochimica et biophysica acta.

[338]  R Pasqualini,et al.  Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. , 1998, The Journal of clinical investigation.

[339]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[340]  S. Perren,et al.  The effect of melt-processing on the degradation of selected polyhydroxyacids: polylactides, polyhydroxybutyrate, and polyhydroxybutyrate-co-valerates , 1993 .

[341]  L. Lowe-Krentz,et al.  Identification of a heparin-binding protein using monoclonal antibodies that block heparin binding to porcine aortic endothelial cells. , 1995, The Biochemical journal.

[342]  H. Lutz,et al.  The Role of Complement Activation in Hypersensitivity to Pegylated Liposomal Doxorubicin (Doxil®) , 2000 .

[343]  M S Newman,et al.  Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes. , 1997, Biochimica et biophysica acta.

[344]  R. Sellers,et al.  The effect of a synthetic anionic polymer (pyran) on the development of foot-and-mouth disease in guinea-pigs, cattle and pigs. , 1972, Research in veterinary science.

[345]  S. Meri,et al.  Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H. , 1994, Biochemical and biophysical research communications.

[346]  P. Couvreur,et al.  Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol). , 1997, Journal of biomedical materials research.

[347]  Bally,et al.  Clearance properties of liposomes involving conjugated proteins for targeting. , 1998, Advanced drug delivery reviews.

[348]  Baguley Bc,et al.  Plasma half-life of cytosine arabinoside (NSC-63878) in patients treated for acute myeloblastic leukemia. , 1971 .

[349]  Z. Cohn,et al.  The macrophage. , 1973, International review of cytology.

[350]  L. Weiss Barrier cells in the spleen. , 1991, Immunology today.

[351]  L. Mayer,et al.  Applications of Liposome Technology to Overcome Multidrug Resistance in Solid Tumors , 1998 .

[352]  D. Knook,et al.  Relation between localization and function of rat liver Kupffer cells. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[353]  H. Yamanaka,et al.  In vivo controlled release of a luteinizing hormone-releasing hormone agonist from poly(dl-lactic acid) formulations of varying degradation pattern , 1991 .

[354]  L. Weiss,et al.  Species variation in the structure and function of the marginal zone--an electron microscope study of cat spleen. , 1981, The American journal of anatomy.

[355]  Antonio Alcami,et al.  Viral mechanisms of immune evasion , 2000, Immunology Today.

[356]  J. Gazzola,et al.  Determination of coating thickness of microcapsules and influence upon diffusion. , 1973, Journal of pharmaceutical sciences.

[357]  J. Ritz,et al.  Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. , 1982, Cancer research.

[358]  W. Regelson,et al.  The Anionic Polyelectrolyte, Polyethylene Sulphonate, as a New Anti-neoplastic Agent , 1958, Nature.

[359]  J. Swanson,et al.  A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages , 1996, The Journal of cell biology.

[360]  R. Souhami,et al.  The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes. , 1981, Biochimica et biophysica acta.

[361]  Chong-Su Cho,et al.  METHOXY POLY(ETHYLENE GLYCOL) AND CAPROLACTONE AMPHIPHILIC BLOCK CO POLYMERIC MICELLE CONTAINING INDOMETHACIN. II: MICELLE FORMATION AND DRUG RELEASE BEHAVIORS , 1998 .

[362]  G Blume,et al.  Liposomes for the sustained drug release in vivo. , 1990, Biochimica et biophysica acta.